Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure
Open Access
- 1 June 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 286 (6) , H2425-H2433
- https://doi.org/10.1152/ajpheart.01045.2003
Abstract
The objective of the present study was to test the hypothesis that endogenous β3-adrenoreceptor (AR) activation contributes to left ventricular (LV) and cardiomyocyte dysfunction in heart failure (CHF). Stimulation of the β3-AR inhibits cardiac contraction. In the failing myocardium, β3-ARs are upregulated, suggesting that stimulation of β3-ARs may contribute to depressed cardiac performance in CHF. We assessed the functional significance of endogenous β3-AR activation in 10 conscious dogs before and after pacing-induced CHF. Under normal conditions, L-748,337, a specific β3-AR antagonist, produced a mild increase in LV contractile performance assessed by the slope ( Ees) of the LV pressure-volume relation (18%, 6.2 ± 0.9 vs. 7.3 ± 1.2 mmHg/ml, P < 0.05) and the improved LV relaxation time constant (τ; 28.4 ± 1.9 vs. 26.8 ± 1.0 ms, P < 0.05). After CHF, the plasma norepinephrine concentration increased eightfold, and L-748,337 produced a larger increase in Ees (34%, 3.8 ± 0.7 vs. 5.1 ± 0.8 mmHg/ml, P < 0.05) and a greater decrease in τ (46.4 ± 4.2 vs. 41.0 ± 3.9 ms, P < 0.05). Similar responses were observed in isolated myocytes harvested from LV biopsies before and after CHF. In the normal myocyte, L-748,337 did not cause significant changes in contraction or relengthening. In contrast, in CHF myocytes, L-748,337 produced significant increases in contraction (5.8 ± 0.9 vs. 6.8 ± 0.9%, P < 0.05) and relengthening (33.5 ± 4.2 vs. 39.7 ± 4.0 μm/s, P < 0.05). The L-748,337-induced myocyte response was associated with improved intracellular Ca2+ concentration regulation. In CHF myocytes, nadolol caused a decrease in contraction and relengthening, and adding isoproterenol to nadolol caused a further depression of myocyte function. Stimulation of β3-AR by endogenous catecholamine contributes to the depression of LV contraction and relaxation in CHF.Keywords
This publication has 43 references indexed in Scilit:
- ?-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human ?-adrenergic receptorCardiovascular Research, 2003
- β-Blockers in Chronic Heart FailureCirculation, 2003
- Potential Use of β3‐Adrenoceptor Antagonists in Heart Failure TherapyCardiovascular Drug Reviews, 2002
- The negative inotropic action of catecholamines: Role of β3-adrenoceptorsCanadian Journal of Physiology and Pharmacology, 2000
- β3-adrenoceptor deficiency blocks nitric oxide–dependent inhibition of myocardial contractilityJournal of Clinical Investigation, 2000
- Heterotrimeric G proteins in heart diseaseCanadian Journal of Physiology and Pharmacology, 2000
- Heterotrimeric G proteins in heart diseaseCanadian Journal of Physiology and Pharmacology, 2000
- The negative inotropic action of catecholamines: Role of β3-adrenoceptorsCanadian Journal of Physiology and Pharmacology, 2000
- β-ADRENERGIC RECEPTORS AND RECEPTOR SIGNALING IN HEART FAILUREAnnual Review of Pharmacology and Toxicology, 1999
- Differential recruitment and differential regulation by physiological amines of fat cell β-1, β-2 and β-3 adrenergic receptors expressed in native fat cells and in transfected cell linesCellular Signalling, 1994